The coronavirus vaccines are not the only subjects that you can see in the spotlight these days.
Viable treatments are also being addressed, and this is making happy a lot of people who are not necessarily trusting the vaccine’s efficiency and are more cautious about the potential side effects.
Experimental antiviral pill for treating Covid cases
CNBC just revealed that Merck said Monday it has asked the FDA to authorize emergency use of its experimental antiviral pill to treat mild to moderate Covid-19 in adults.
The U.S. drugmaker’s request comes right following phase three clinical trial data released on Oct. 1.
This reportedly showed that the medication – known as molnupiravir – reduced the chances that patients newly diagnosed with Covid would be hospitalized by about 50%.
According to the official notes, the drug is able to inhibit the replication of the virus inside the body.
Unlike Gilead Sciences’ intravenous drug remdesivir, Merck’s molnupiravir can be taken by mouth, CNBC says.
A potentially game-changing treatment
If this drug sees a successful path and it is approved by U.S. regulators, it would be the first pill to treat Covid – this is definitely a potentially game-changing advancement in the fight against the virus.
“The extraordinary impact of this pandemic demands that we move with unprecedented urgency, and that is what our teams have done by submitting this application for molnupiravir to the FDA within 10 days of receiving the data.”
This is what Merck CEO Robert Davis said in a press release.
It’s been also revealed that the pill could be available to Americans by late this year. Merck also made sure to point out the fact that it is actively working with regulatory agencies all over the world in order to submit applications for emergency use or authorization “in the coming months.” Stay tuned for more news.
Also, make sure to check out some interesting facts about mandatory covid vaccines.